AEMD — AETHLON MEDICAL INC

—
Nasdaq · Health Care · Pharmaceuticals · CIK 882291 ·
Last close
$5.08
Market Cap
$8.17M
52W High
$24.75
52W Low
$1.41
ADV30
45,715
Next earnings
2027-02-11
Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 — — — — — — —
Mar 2026 0 — -1,929,296 -1,884,266 6,333,107 5,026,458 1,446,835
Dec 2025 0 — -2,062,116 -2,018,245 8,057,128 6,956,397 1,344,031
Sep 2025 0 — -1,509,830 -1,487,100 7,323,090 5,853,493 1,577,113

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-6,998,392
Investing CF
$141
Financing CF
$6,521,904
CapEx
$-2,051
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-77.39
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-175,106,286
Inventory
—
Receivables
$218,314
ST Investments
—
EBIT TTM
$-7,137,098
Pretax Income TTM
$-7,151,469
Interest Exp TTM
—
Analysts
2

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 0 -7,293,631 -7,151,469 6,330,000 1,446,835 4,886,272 -6,998,392
Mar 2025 0 -9,341,365 -13,388,089 7,359,534 2,236,004 5,123,530 -7,645,532
Mar 2024 0 -12,636,568 -12,208,174 8,245,982 2,479,650 5,766,332 -10,129,810
Mar 2023 574,245 -11,898,638 -12,029,786 17,508,940 2,444,730 15,064,210 -10,505,128
Mar 2022 — — — — — — —

TTM Snapshot

Revenues TTM
$156,534
NetIncome TTM
$-6,937,523
OpCashFlow TTM
—
Assets (Latest)
$6,235,371
Forward EPS
$-0.57

Peers — same industry

TickerNameMarket CapLastDaily %
MTVA MetaVia Inc. $8.24M $1.25 —
KYNB KYNTRA BIO, INC. $8.26M $2.04 —
VTGN Vistagen Therapeutics, Inc. $8.34M $0.19 —
CALC CalciMedica, Inc. $8.41M $1.22 —
DARE Dare Bioscience, Inc. $8.44M $0.43 —

News headlines (Yahoo Finance, 1h cache)

Aethlon Medical Reports Second Quarter Fiscal 2027 Results and Provides Corporate Update
2026-11-12 21:30 · Yahoo
Aethlon Medical Shares Surge Over 400% After Announcing North Immunology Merger
2026-09-17 12:36 · Yahoo
North Immunology joins biotech reverse merger boom with Aethlon deal
2026-09-17 11:09 · Yahoo
Aethlon Medical & North Immunology Announce Merger to Advance Novel IL-13 x IL-18 Bispecific Antibody for Atopic Dermatitis
2026-09-17 10:30 · Yahoo
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
2026-08-13 20:15 · Yahoo
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
2026-07-13 12:01 · Yahoo
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
2026-07-06 13:25 · Yahoo
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
2026-06-26 12:01 · Yahoo
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Strategic Advances Amid Financial ...
2026-06-17 01:00 · Yahoo
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion
2026-06-17 16:18 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.